Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
AZNAstraZeneca PLC (US) Live data
$184.81▼ -1.97 (-1.1%)as of Nov 11, 2026, 6:28 PM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$87.23$212.71
1-Month Range
Month up 18.6%
$155.82$189.39
Daily Price Range
Day down -1.1%
$183.53$185.11
Volume
vs 3M avg
7964003M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$286.1B
Short % of Float—
Employees—
Sales—
Shares Outstanding1,548,238,732
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.azn.com
AstraZeneca PLC (US) — is a public issuer in the Vantage universe..
Warnings
1 signal
Live
- Price 112% above 52-week low — momentum stretched
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for AZN.
Price targets unavailable — no 12-month targets on file for AZN.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on AZN, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:28 PM UTC